MANH vs ORCL: Which Is the Better Buy in 2026?
Last updated September 2026
Short answer
ORCL is the larger of the two ($407.07B market cap): the incumbent the market prices for continued execution (12.93x forward earnings, beta 1.72). MANH is the smaller challenger ($12.61B), actually pricier on forward earnings (35.24x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
MANH vs ORCL: the tie-breaker metrics
Same yardstick, side by side (as of September 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | MANH | ORCL | What it tells you |
|---|---|---|---|
| Market cap | $12.61B | $407.07B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 35.24 | 12.93 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 62.13 | 24.20 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.93 | 1.72 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 90% of range | 12% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 80.02 | 10.84 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: ORCL is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how MANH and ORCL affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. MANH and ORCL share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined MANH and ORCL exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Manhattan Associates (MANH) do?
Manhattan Associates (MANH) builds supply chain and omnichannel commerce software used by large retailers, wholesalers, manufacturers, and logistics providers. Its core products are warehouse management (WMS), transportation management (TMS), and order management and point-of-sale systems, unified under the cloud-native Manhattan Active platform. The software helps companies run distribution centers, route freight, manage inventory across channels, and fulfill orders, and Manhattan pairs it with a large professional services organization that implements and configures the systems. Founded in 1990 and headquartered in Atlanta, Manhattan is widely regarded as a leader in warehouse and transportation execution, competing on depth of functionality and high customer win rates rather than on being the cheapest option.
What does Oracle (ORCL) do?
Oracle is one of the largest enterprise software companies in the world. The traditional business is database software (the Oracle Database is the dominant enterprise relational database), enterprise applications (Oracle ERP, HCM, CRM via the Fusion suite, plus NetSuite for smaller businesses), and Java (Oracle owns and maintains the Java platform). These are mature, sticky, high-margin businesses.
MANH vs ORCL: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- MANH drivers: Cloud subscription momentum; Rising RPO and backlog visibility.
- ORCL drivers: Oracle Cloud Infrastructure (OCI) AI deals; Database and applications as the cash cow.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The largest risk is valuation: MANH trades at a premium software multiple, so any deceleration in cloud growth, bookings, or RPO can trigger sharp multiple compression. For ORCL, aI cloud deals carry execution risk: massive datacenter buildouts must be delivered on time, profitably.
MANH or ORCL: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick MANH if you believe its drivers more; ORCL if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the MANH and ORCL guides.
MANH vs ORCL: the full fundamentals
MANH. Manhattan trades at a premium multiple that reflects its category leadership, recurring cloud model, and expanding backlog rather than its headline revenue growth, which is in the high single digits during the cloud transition. Management raised full-year 2026 adjusted EPS guidance to roughly $5.29 to $5.37 after a first quarter that beat on revenue. The valuation prices in continued execution, so the stock is sensitive to any wobble in cloud bookings or RPO.
ORCL. Oracle's valuation has re-rated meaningfully higher as the market has come to view it as an AI cloud beneficiary rather than just a legacy database company. The multiple expansion is justified if AI cloud bookings continue; it compresses quickly if growth stalls.
Headline figures (approximate, JULY 2026): MANH shows revenue (ttm) ~$1.1 billion, 2026 revenue guidance ~$1.147 to $1.157 billion, cloud subscription growth ~24% year over year, rpo (backlog) ~$2.35 billion, up ~24%; ORCL shows revenue (ttm) ~$58 billion, operating margin ~30% (compressed by AI capex), net income (ttm) ~$13 billion, eps (ttm) ~$4.50.
The bottom line: MANH vs ORCL
MANH and ORCL are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined MANH and ORCL exposure against your real portfolio. It is not an investment adviser.
Wondering how MANH or ORCL fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Manhattan Associates with AI
Connect the broker you already use and ask Walnut's AI how MANH fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between MANH and ORCL?
+
Manhattan Associates (MANH) builds supply chain and omnichannel commerce software used by large retailers, wholesalers, manufacturers, and logistics providers. Oracle is one of the largest enterprise software companies in the world. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is MANH or ORCL the better stock?
+
Neither is universally better. ORCL is the larger incumbent; MANH is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, MANH or ORCL?
+
On forward P/E (as of September 2026), MANH trades at 35.24x and ORCL at 12.93x, so ORCL is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both MANH and ORCL?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of MANH vs ORCL?
+
MANH: The largest risk is valuation: MANH trades at a premium software multiple, so any deceleration in cloud growth, bookings, or RPO can trigger sharp multiple compression. Services revenue, roughly half of total revenue, is lower margin and more sensitive to customer implementation budgets, which can soften in a weak economy or when retail and logistics capital spending slows. Manhattan competes with much larger players such as SAP, Oracle, and Panasonic-owned Blue Yonder that can bundle supply chain modules under existing ERP relationships. Large enterprise deals can be lumpy and elongate in uncertain macro conditions, and the cloud transition, while improving revenue quality, caps near-term reported growth as license revenue disappears. Execution on AI features is promising but unproven at scale. ORCL: AI cloud deals carry execution risk: massive datacenter buildouts must be delivered on time, profitably. If AI capex demand cools, the buildout becomes a stranded asset risk.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell MANH or ORCL; figures are approximate and dated (as of September 2026). Verify current data before investing.